Association between tumor mutations and meningioma recurrence in Grade I/II disease
Open Access
- 9 December 2022
- journal article
- research article
- Published by Impact Journals, LLC in Oncoscience
- Vol. 9, 70-81
Abstract
Https://doi.org/10.18632/oncoscience.570 Jonathan T. Dullea, Vikram Vasan, John W. Rutland, Corey M. Gill, Danielle Chaluts, Daniel Ranti, Ethan Ellis, Varun Subramanium, Annie Arrighi-Allisan, Yayoi Kinoshita, Russell B. McBride, Joshua Bederson, Michael Donovan, Robert Sebra, Melissa Umphlett, Raj K. ShrivastavaKeywords
This publication has 31 references indexed in Scilit:
- ATM Mutations in Cancer: Therapeutic ImplicationsMolecular Cancer Therapeutics, 2016
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summaryActa Neuropathologica, 2016
- Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomesJournal of Neurosurgery, 2016
- POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial CancerClinical Cancer Research, 2015
- Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutationsLaboratory Investigation, 2015
- Genomic Analysis of Non- NF2 Meningiomas Reveals Mutations in TRAF7 , KLF4 , AKT1 , and SMOScience, 2013
- Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutationsNature Genetics, 2013
- Eukaryotic DNA polymerases require an iron-sulfur cluster for the formation of active complexesNature Chemical Biology, 2011
- DNA polymerases and cancerNature Reviews Cancer, 2011
- Genetic variation in p53 and ATM haplotypes and risk of glioma and meningiomaJournal of Neuro-Oncology, 2006